245 related articles for article (PubMed ID: 23861973)
1. Arsenic trioxide prevents osteosarcoma growth by inhibition of GLI transcription via DNA damage accumulation.
Nakamura S; Nagano S; Nagao H; Ishidou Y; Yokouchi M; Abematsu M; Yamamoto T; Komiya S; Setoguchi T
PLoS One; 2013; 8(7):e69466. PubMed ID: 23861973
[TBL] [Abstract][Full Text] [Related]
2. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway.
Beauchamp EM; Ringer L; Bulut G; Sajwan KP; Hall MD; Lee YC; Peaceman D; Ozdemirli M; Rodriguez O; Macdonald TJ; Albanese C; Toretsky JA; Uren A
J Clin Invest; 2011 Jan; 121(1):148-60. PubMed ID: 21183792
[TBL] [Abstract][Full Text] [Related]
4. Melarsomine suppresses canine osteosarcoma cell survival via inhibition of Hedgehog-GLI signaling.
Nam A; Kim T; Li Q; Rebhun RB; Youn HY; Seo KW
J Vet Med Sci; 2019 Dec; 81(12):1722-1729. PubMed ID: 31645504
[TBL] [Abstract][Full Text] [Related]
5. Smoothened as a new therapeutic target for human osteosarcoma.
Hirotsu M; Setoguchi T; Sasaki H; Matsunoshita Y; Gao H; Nagao H; Kunigou O; Komiya S
Mol Cancer; 2010 Jan; 9():5. PubMed ID: 20067614
[TBL] [Abstract][Full Text] [Related]
6. Arsenic trioxide inhibits the Hedgehog pathway which is aberrantly activated in acute promyelocytic leukemia.
Yang D; Cao F; Ye X; Zhao H; Liu X; Li Y; Shi C; Wang H; Zhou J
Acta Haematol; 2013; 130(4):260-7. PubMed ID: 23867347
[TBL] [Abstract][Full Text] [Related]
7. Arsenic Trioxide inhibits Activation of Hedgehog Pathway in Human Neuroblastoma Cell Line SK-N-BE(2) Independent of Itraconazole.
Liu X; Wang Z; Xiong X; Li C; Wu Y; Su M; Yang S; Zeng M; Weng W; Huang K; Zhou D; Fang J; Xu L; Li P; Zhu Y; Qiu K; Ma Y; Lei J; Li Y
Anticancer Agents Med Chem; 2023; 23(20):2217-2224. PubMed ID: 37888819
[TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide induces Noxa-dependent apoptosis in rhabdomyosarcoma cells and synergizes with antimicrotubule drugs.
Meister MT; Boedicker C; Graab U; Hugle M; Hahn H; Klingebiel T; Fulda S
Cancer Lett; 2016 Oct; 381(2):287-95. PubMed ID: 27521572
[TBL] [Abstract][Full Text] [Related]
9. The GLI genes as the molecular switch in disrupting Hedgehog signaling in colon cancer.
Mazumdar T; DeVecchio J; Agyeman A; Shi T; Houghton JA
Oncotarget; 2011 Aug; 2(8):638-45. PubMed ID: 21860067
[TBL] [Abstract][Full Text] [Related]
10. Involvement and targeted intervention of dysregulated Hedgehog signaling in osteosarcoma.
Lo WW; Wunder JS; Dickson BC; Campbell V; McGovern K; Alman BA; Andrulis IL
Cancer; 2014 Feb; 120(4):537-47. PubMed ID: 24151134
[TBL] [Abstract][Full Text] [Related]
11. Blocking Hedgehog survival signaling at the level of the GLI genes induces DNA damage and extensive cell death in human colon carcinoma cells.
Mazumdar T; Devecchio J; Agyeman A; Shi T; Houghton JA
Cancer Res; 2011 Sep; 71(17):5904-14. PubMed ID: 21747117
[TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide inhibits tumor cell growth in malignant rhabdoid tumors in vitro and in vivo by targeting overexpressed Gli1.
Kerl K; Moreno N; Holsten T; Ahlfeld J; Mertins J; Hotfilder M; Kool M; Bartelheim K; Schleicher S; Handgretinger R; Schüller U; Meisterernst M; Frühwald MC
Int J Cancer; 2014 Aug; 135(4):989-95. PubMed ID: 24420698
[TBL] [Abstract][Full Text] [Related]
13. Targeting hedgehog signalling by arsenic trioxide reduces cell growth and induces apoptosis in rhabdomyosarcoma.
Boehme KA; Zaborski JJ; Riester R; Schweiss SK; Hopp U; Traub F; Kluba T; Handgretinger R; Schleicher SB
Int J Oncol; 2016 Feb; 48(2):801-12. PubMed ID: 26676886
[TBL] [Abstract][Full Text] [Related]
14. Combination of Hedgehog inhibitors and standard anticancer agents synergistically prevent osteosarcoma growth.
Saitoh Y; Setoguchi T; Nagata M; Tsuru A; Nakamura S; Nagano S; Ishidou Y; Nagao-Kitamoto H; Yokouchi M; Maeda S; Tanimoto A; Furukawa T; Komiya S
Int J Oncol; 2016 Jan; 48(1):235-42. PubMed ID: 26548578
[TBL] [Abstract][Full Text] [Related]
15. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC
Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618
[TBL] [Abstract][Full Text] [Related]
16. Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector.
Kim J; Lee JJ; Kim J; Gardner D; Beachy PA
Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13432-7. PubMed ID: 20624968
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of thymidylate synthase and E2F1 by arsenic trioxide in mesothelioma.
Lam SK; Li YY; Zheng CY; Ho JC
Int J Oncol; 2015 Jan; 46(1):113-22. PubMed ID: 25335113
[TBL] [Abstract][Full Text] [Related]
18. Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma.
Lam SK; Leung LL; Li YY; Zheng CY; Ho JC
Lung Cancer; 2016 Nov; 101():111-119. PubMed ID: 27794399
[TBL] [Abstract][Full Text] [Related]
19. TG-interacting factor transcriptionally induced by AKT/FOXO3A is a negative regulator that antagonizes arsenic trioxide-induced cancer cell apoptosis.
Liu ZM; Tseng HY; Cheng YL; Yeh BW; Wu WJ; Huang HS
Toxicol Appl Pharmacol; 2015 May; 285(1):41-50. PubMed ID: 25791921
[TBL] [Abstract][Full Text] [Related]
20. Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.
Ling S; Xie H; Yang F; Shan Q; Dai H; Zhuo J; Wei X; Song P; Zhou L; Xu X; Zheng S
J Hematol Oncol; 2017 Feb; 10(1):59. PubMed ID: 28241849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
